SBC-115076

CAS No. 489415-96-5

SBC-115076( SBC-115076 | SBC 115076 | SBC115076. )

Catalog No. M17523 CAS No. 489415-96-5

SBC-115076 is a potent extracellular proprotein convertase subtilisin kexin type 9 (PCSK9) antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 43 In Stock
5MG 69 In Stock
10MG 91 In Stock
25MG 171 In Stock
50MG 309 In Stock
100MG 478 In Stock
500MG 1062 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SBC-115076
  • Note
    Research use only, not for human use.
  • Brief Description
    SBC-115076 is a potent extracellular proprotein convertase subtilisin kexin type 9 (PCSK9) antagonist.
  • Description
    SBC-115076 is a potent extracellular proprotein convertase subtilisin kexin type 9 (PCSK9) antagonist.
  • In Vitro
    ——
  • In Vivo
    Animal Model:Female Wistar rats (high-fat diet (HFD)- fed) Dosage:4 mg/kg Administration:S.c.; daily for 3 weeks Result:Superior to atorvastatin in instigating weight loss, cholesterol reduction, and attenuation of mitochondrial oxidative stress in oxidative muscle fibers of obese female rats.
  • Synonyms
    SBC-115076 | SBC 115076 | SBC115076.
  • Pathway
    Tyrosine Kinase
  • Target
    Src
  • Recptor
    PCSK9
  • Research Area
    Cardiovascular Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    489415-96-5
  • Formula Weight
    527.61
  • Molecular Formula
    C31H33N3O5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 32 mg/mL; 60.65 mM
  • SMILES
    Cc1cc(C(=O)C2=C(O)C(=O)N(C2c2ccncc2)CCCN2CCOCC2)ccc1OCc1ccccc1
  • Chemical Name
    4-(4-(benzyloxy)-3-methylbenzoyl)-3-hydroxy-1-(3-morpholinopropyl)-5-(pyridin-4-yl)-1H-pyrrol-2(5H)-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Abdel-Meguid SS, et al. WO2014150326 A1.
molnova catalog
related products
  • KX2-391

    KX2-391, the first clinical Src inhibitor (peptidomimetic class) that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines.

  • RK-24466

    RK-24466 is a selective and potent inhibitor of Lck, inhibits Lck (64-509) and LckCD isoforms with IC50s of less than 1 and 2 nM, respectively.

  • eCF506

    eCF506 is a potent and selective inhibitor of SRC (IC50 < 0.5 nM)eCF506, the first small molecule with subnanomolar IC50 for SRC that requires 3 orders of magnitude greater concentration to inhibit ABL.?